Overview

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Status:
Recruiting

Trial end date:
2024-07-01

Target enrollment:

Participant gender:

Summary

A study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).

Phase:

Phase 2

Details

Lead Sponsor:

Kowa Research Institute, Inc.

Treatments:

6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol